This report provides a summary and key points of presentations and discussions made during an IPC symposium presented by IPC's Research Committee held during the Society of Investigative Dermatology (SID) Annual Meeting in Chicago, IL, USA
download
SYMPOSIUM REPORT - Challenging Cases: A focus on pediatrics, comorbidities, infections, & biologics
This report provides a summary and key points of presentations and challenging case discussions made during an IPC symposium held during the Skin Inflammation and Psoriasis International Network (SPIN) Congress in Paris, France
psoriasis and atopic dermatitis: similarities and differences
A joint publication of the International Eczema Council (IEC) and the International Psoriasis Council (IPC)
2018 IPC Think tank meeting report
This report provides a meeting summary and key points of presentations and discussions held during IPC's 2018 Think Tank
GLOBAL PSORIASIS ATLAS ANNUAL REPORT 2019
The annual report highlights the outcomes for Year 2: April 2018-March 2019
p4 medicine: Personalized, predictive, preventive, participatory medicine in a digital environment - HOW CAN THE INTERNATIONAL PSORIASIS COUNCIL CONTRIBUTE?
An IPC written article discussing the importance of the P4 approach to medicine
Global Psoriasis Atlas Annual Report 2018
The annual report highlights the outcomes for Year 1: April 2017-March 2018
The IPC contributed to the the WHO Global Report on Psoriasis (2016) and subsequently launched the Global Psoriasis Atlas project in April 2017
UPCOMING EVENT The mechanistic model(s) of psoriasis: Autoimmune and/or inflammatory? Wednesday, September 18, 2019 2:00 pm - 6:00 pm Bordeaux, france Register Now
Psoriasis News Announcing IPC's Newest Corporate Partner: Ortho Dermatologics9/3/2019 11:11:00 AM Get Connected: World Psoriasis Day 20199/3/2019 9:41:00 AM In Memory of Gladys León Dorantes9/2/2019 3:24:00 PM Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council8/29/2019 7:13:00 AMPsoriasis severity categories have been important tools for clinicians to use in treatment decisions as well as to determine eligibility criteria for clinical studies. However, due to the heterogeneity of severity classifications and their lack of consideration for the impact of psoriasis involvement of special areas or past treatment history, patients may be mis-categorized, which can lead to under-treatment of psoriasis. More News